13F Holdings
中文EN

ARAY ACCURAY INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1138723 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY-12.5%
TTM net income YoY10.0%
TTM EPS YoY22.0%
Revenue 3-yr CAGR-4.6%
Net income 3-yr CAGR—

Margins

Gross margin28.0%
Operating margin-13.1%
Net margin-4.4%
FCF margin-6.9%
EBITDA margin-11.2%

Returns

ROE-30.2%
ROA-4.1%
ROIC (approx.)-32.5%
Asset turnover0.93x

Leverage & solvency

Liabilities / assets86.4%
Debt / equity1.91x
Current ratio1.56x
Interest coverage-1.41x

Cash quality & payout

Operating cash flow / net income1.32x
Accruals ratio1.3%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30FY20242024-06-30FY20232023-06-30FY20222022-06-30
Income statement
Revenue$401.95M$458.50M$446.55M$447.61M$429.91M
Cost of revenue$290.49M$311.54M$303.63M$293.64M$269.95M
Gross profit$111.45M$146.97M$142.92M$153.96M$159.96M
R&D expense$37.75M$47.94M$49.73M$57.13M$57.75M
SG&A expense$45.40M$47.87M$50.07M$48.27M$44.39M
Operating income-$26.44M$7.84M$504,000$2.38M$8.15M
Interest expense$32.91M$12.95M$11.62M$10.63M$8.13M
Pretax income-$47.25M$1.13M-$11.82M-$6.79M-$2.00M
Income tax$1.95M$2.73M$3.73M$2.49M$3.35M
Net income-$49.19M-$1.59M-$15.54M-$9.28M-$5.35M
EBITDA-$18.50M$13.99M$6.41M$6.91M$13.66M
EPS (basic)-0.40-0.02-0.16-0.10-0.06
EPS (diluted)—-0.02-0.16-0.10-0.06
Weighted avg. shares (diluted)—102.77M98.27M94.88M92.09M
Banking
Provision for credit losses$573,000-$101,000-$479,000——
Balance sheet
Cash & equivalents$40.62M$57.42M$68.57M$91.20M$90.15M
Receivables$67.41M$83.19M$92.00M$74.78M$94.44M
Inventory$147.07M$141.02M$138.32M$145.15M$142.25M
Current assets$287.78M$317.46M$323.24M$338.03M$350.89M
PP&E, net$27.32M$28.66M$24.77M$20.93M$12.69M
Goodwill$57.91M$57.80M$57.67M$57.68M$57.84M
Intangibles$0$15,000$59,000$210,000$250,000
Total assets$443.68M$470.24M$468.63M$479.21M$472.85M
Current liabilities$191.41M$192.58M$195.27M$198.64M$208.86M
Short-term debt$1.50M$12.73M$7.76M$5.72M$8.56M
Long-term debt$146.37M$123.79M$164.40M$171.56M$171.91M
Total debt$147.87M$136.52M$172.16M$177.28M$180.47M
Total liabilities$401.98M$389.07M$423.54M$425.56M$419.66M
Shareholders' equity$41.70M$81.17M$45.08M$53.66M$53.19M
Net debt$107.25M$79.10M$103.59M$86.08M$90.32M
Shares outstanding119.43M112.64M100.19M96.53M93.50M
Cash flow statement
Operating cash flow-$6.98M$2.86M-$11.90M$15.54M-$2.40M
Capital expenditure$5.86M$4.27M$3.60M$12.61M$4.72M
Free cash flow-$12.84M-$1.41M-$15.51M$2.92M-$7.12M
Investing cash flow-$12.28M-$8.52M-$3.60M-$12.68M-$4.72M
Financing cash flow$6.98M-$4.25M-$3.95M-$2.11M-$15.37M
Depreciation & amortization$7.94M$6.15M$5.91M$4.53M$5.51M
Stock-based compensation$6.46M$10.20M$9.48M$10.05M$10.60M
Share buybacks———$0$0

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.